- Home
- ICCM
ICCM
IceCure Medical Ltd.
as 07-26-2024 4:00pm EST
Stocks
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
| Founded: | 2006 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 36.0M | IPO Year: | N/A |
| Target Price: | $2.95 | AVG Volume (30 days): | 419.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.52 - $1.57 | Next Earning Date: | 08-12-2024 |
| Revenue: | $3,262,000 | Revenue Growth: | 7.02% |
| Revenue Growth (this year): | 16.85% | Revenue Growth (next year): | 57.25% |
Latest IceCure Medical Ltd. News
ICCM Breaking Stock News: Dive into ICCM Ticker-Specific Updates for Smart Investing
Medical Device Network
4 days ago
IceCure presents hat-trick of positive trial data for cryoablation device
PR Newswire
5 days ago
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society
Medical Device Network
5 days ago
IceCure Medical receives Nasdaq compliance notice
PR Newswire
7 days ago
IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification
Zacks
15 days ago
IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint
PR Newswire
18 days ago
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer
Zacks
23 days ago
IceCure Medical (ICCM) New Cryoablation System Gets FDA Nod
Medical Device Network
25 days ago
FDA grants marketing authorisation for IceCure’s XSense Cryoablation System
Compare ICCM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICCM IceCure Medical Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.